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Granulosa cell endothelin-2 
expression is fundamental for 
ovulatory follicle rupture
Joseph A. Cacioppo  1, Po-Ching Patrick Lin1, Patrick R. Hannon1,2, Daniel R. McDougle1, 
Arnon Gal1,3 & CheMyong Ko1
Ovulation is dependent upon numerous factors mediating follicular growth, vascularization, and 
ultimately oocyte release via follicle rupture. Endothelin-2 (EDN2) is a potent vasoconstrictor that is 
transiently produced prior to follicle rupture by granulosa cells of periovulatory follicles and induces 
ovarian contraction. To determine the role of Edn2 expression, surgical transplant and novel conditional 
knockout mice were super-ovulated and analyzed. Conditional knockout mice utilized a new iCre 
driven by the Esr2 promoter to selectively remove Edn2. Follicle rupture and fertility were significantly 
impaired in the absence of ovarian Edn2 expression. When ovaries of Edn2KO mice were transplanted 
in wild type recipients, significantly more corpora lutea containing un-ovulated oocytes were present 
after hormonal stimulation (1.0 vs. 5.4, p = 0.010). Following selective ablation of Edn2 in granulosa 
cells, Esr2-Edn2KO dams had reduced oocytes ovulated (3.8 vs. 16.4 oocytes/ovary) and smaller litters 
(4.29 ± l.02 vs. 8.50 pups/dam). However, the number of pregnancies per pairing was not different and 
the reproductive axis remained intact. Esr2-Edn2KO ovaries had a higher percentage of antral follicles 
and fewer corpora lutea; follicles progressed to the antral stage but many were unable to rupture. 
Conditional loss of endothelin receptor A in granulosa cells also decreased ovulation but did not affect 
fecundity. These data demonstrate that EDN2-induced intraovarian contraction is a critical trigger of 
normal ovulation and subsequent fecundity.
Endothelin-2 (Edn2) encodes a short 21-amino acid peptide1. EDN2 is one of three similar isoforms in the body 
that act through two endothelin receptors (EDNRA and EDNRB)2, 3. Edn2 is expressed in the gastrointestinal 
tract, prostate, skin, testes, and notably is known to be transiently expressed in the stimulated rodent and human 
ovary4. Edn2 mRNA is expressed in murine granulosa cells of mature ovarian follicles immediately prior to 
ovulation for approximately two hours3, 5–7. This period corresponds to ovulation and early corpus luteum (CL) 
formation in the mouse. When ovulation is induced through hormone injection, Edn2 expression occurs from 
11–12 hours after hCG injection while ovulation occurs at approximately 12 hours after injection8, 9. EDN2 has 
been shown to be important for ovulation and CL formation through pharmacological inhibition and global 
knockout mouse approaches5, 6, 10.
EDN2 assists in mediating ovulation by inducing follicular contraction for oocyte expulsion. Endothelin 
receptor A (EDNRA) is localized in the theca externa layer of the ovarian follicle and in the associated smooth 
muscle of arteries and arterioles in both rodents and humans7, 11, 12. Alternatively, endothelin receptor B (EDNRB) 
is expressed largely in endothelial cells13 where it acts to clear endothelins from circulation14–17. EDN2 signaling 
through EDNRA induces smooth muscle contraction resulting in oocyte expulsion18, 19, specifically at the apex of 
the follicle wall18 where fewer contractile cells are present20–22. Chemically-induced ovarian contraction has been 
documented in the human23–25, cat26, and rabbit27–29. Previous work by Bridges et al. using receptor antagonists 
support that EDNRA is the critical receptor involved in ovulation: EDN2-mediated contraction was reduced by a 
specific EDNRA antagonist but not by a specific EDNRB antagonist3, 11. Additionally, mice that conditionally lack 
EDNRB demonstrate no reproductive deficits and instead give birth to more pups per litter and produce more 
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corpora lutea30. Most recently, EDN2-induced contraction and follicular rupture has been visualized through 
pharmacological antagonist treatment and intravital multiphoton microscopy by Migone et al.18.
The present study was undertaken to confirm and expand upon the significance of Edn2 expression in follicu-
logenesis, ovulation, and overall fertility/fecundity. It extends previous studies on EDN2 in ovulation that utilized 
pharmacological inhibition and global knockout animals. The present study generates novel mouse models with 
ovarian-specific Edn2 loss, characterizes their reproductive phenotypes, and quantifies the effect of EDN2 as a 
contractile agonist on ovaries ex vivo. We hypothesized that mice lacking Edn2 in all or part of the ovary will have 
decreased oocytes ovulated and consequently smaller litter sizes, with fewer or no corresponding corpora lutea; 
these mice would maintain normal ovarian development and folliculogenesis until ovulation. Two novel mouse 
model systems were utilized for this purpose. The Edn2 gene was ablated in the entire ovary and also specifically 
in the granulosa cells using the Cre/LoxP system31 in an Edn2-flox mouse line.
A mouse strain that globally lacks Edn232 was first used to examine the role of EDN2 in ovarian development 
and early follicular growth, and then in hormonally induced ovulation. EDN2 global knockout (Edn2KO) mice 
expire from starvation, hypothermia, and/or emphysema33, and have impaired ovulatory abilities as well as other 
defects10. Global Edn2 loss is lethal to juveniles at approximately eight days of age, and organ transplant to healthy 
WT recipients was used to overcome this barrier to generate a mouse model that lacks Edn2 in the ovary only. 
This ovary-specific Edn2 ablation was achieved by transplanting ovaries of global Edn2KO to the kidney capsule 
of ovariectomized wild type (WT) mice to create a novel mouse model for examining the role of EDN2 in folli-
cular development and ovulation.
Second, conditional Edn2 ablation in the ovary was achieved by crossing floxed Edn2 mice with mouse lines 
that express Cre recombinase driven by promoters for either progesterone receptor (Pgr, Pgr-Cre)34, aromatase 
(Cyp19; Cyp19-iCre)35, or estrogen receptor beta (Esr2, Esr2-iCre)36–40. These three conditional knockout mod-
els were generated to induce Edn2 deletion in the granulosa cells at different stages of follicular development. 
Timing of genetic ablation via these Cre mice ranges from the primary follicle stage (Esr2-iCre)37, 41–43 to the 
secondary follicle stage (Cyp19-iCre)44–46, and to just six hours before ovulation (Pgr-Cre)47, 48, allowing selective 
removal of Edn2 at different time points during follicular development and ovulation. Lastly, the significance of 
EDNRA-mediated contraction in ovulation was assessed by a selective ablation of Ednra in the ovarian cells and 
its impact on ovulation and ovarian contractility.
Results
Global Edn2KO mice have normal follicular development. Global Edn2 knockout (Edn2KO) mice 
were generated by breeding floxed Edn2 mice (Edn2Flox) with Zp3-Cre mice, allowing Cre-mediated gene dele-
tion at the oocyte stage32. The Edn2KO mice generated were comparable to previous reports on global Edn2 loss 
by Chang et al.33: mice were unhealthy and generally expired by 8–10 days of age (range 0–18 days). Edn2KO mice 
were noticeably smaller by post-natal day 6 (PND6) despite heat/nutritional supplementation with Peptamen 
(Nestle), which suggests that observed growth retardation was due to starvation or early postnatal developmen-
tal defects (Fig. 1A). Although nearly half the size of their wild type (WT) siblings at PND6, ovarian/follicular 
development was largely unaffected. Ovaries examined at PND6 appear histologically normal (Fig. 1B) and had 
follicles of all expected levels of maturity. There was no difference between Edn2KO and WT ovaries in the abso-
lute numbers of germ cells, primordial, primary, or preantral follicles per ovary (Fig. 1C). Additionally, there was 
no difference in the percentage of these follicles relative to total follicle plus germ cell number, except germ cell 
Figure 1. Edn2KO PND6 pups are smaller but have normal ovarian development. (A) Average body mass 
at post-natal day 6 (PND6) of WT (4.12 ± 0.25 g) vs Edn2KO (2.25 ± 0.10 g) pups. (B) Representative PND6 
WT and Edn2KO ovaries sectioned at 5 μM. Histology images are shown at 10X and 20X. Both ovaries have a 
mix of germ cells, primordial follicles, primary follicles, and several preantral follicles. (C) Follicle and germ 
cell counting was performed on PND6 WT and Edn2KO and control ovaries (n = 10). Absolute cell counts are 
displayed above and the percentage of total cells per ovary is displayed below. A significant difference was seen 
between the percentage of germ cells present (p = 0.007). No other significant differences were noted. Error bars 
display the S.E.M.
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percentages were slightly elevated (p = 0.007) in Edn2KO PND6 ovaries. These data indicate that germ cell matu-
ration to the primordial follicle stage proceeds normally to PND6 in the absence of EDN2.
Ovulation is impaired in the Edn2-deficient ovary. To determine the ovary-specific role of EDN2, 
Edn2KO ovaries and WT controls were removed at PND6 and grafted under the kidney capsule of ovariecto-
mized (OVX) WT mice, generating Edn2KO Kidney-Ovary-Transplant (KOT) ovaries and WT KOT ovaries, 
respectively. This was employed to remove confounding systemic effects of Edn2 loss. Ovaries were given time to 
mature to 24 days of age as response to gonadotropin stimulation is observed in WT intact mice by this age, and 
mice with surgical treatment had resumed normal estrous cycling by vaginal cytology at this time. At the grafted 
ovarian age of 24 days, ovulation was induced by injecting gonadotropins and ovaries and sera were collected 
at hCG 12 and hCG 24 hours (Fig. 2A). Quantitative RT-PCR was performed at hCG 12 hours to test that Edn2 
expression remained absent in Edn2KO KOT ovaries. Additionally, Edn1 expression was examined due to its abil-
ity to signal via the same endothelin receptors with comparable affinity to EDN249. Expression of Edn2 was absent 
in Edn2KO KOT ovaries (red), indicating that ovarian EDN2 production did not occur after surgical graft nor 
after ovulation induction (Fig. 2B). Surprisingly, expression of Edn1 was decreased (p = 0.006) in the grafted ova-
ries and compensatory expression did not occur. When histologically examined at hCG 24 hours, corpora lutea 
(CL) and antral follicles (AF) were present in both Edn2KO KOT ovaries and WT KOT ovaries (light blue), and 
WT intact age-matched mice (Fig. 2C). To quantitatively explore folliculogenesis, ovaries from hCG24 hours were 
serially sectioned and the numbers of follicles were compared among the groups. By absolute count per ovary, 
Figure 2. Edn2KO ovaries grafted under the kidney capsule have decreased ovulatory ability. (A) Experimental 
plan for WT and Edn2KO ovary grafting. Pups were euthanized at post-natal day 6 (PND6) and ovaries were 
grafted under the kidney capsule of 28–32 day old control females. Mice were then superovulated 18 days after 
transplantation and ovaries were collected. (B) Ovaries were collected at hCG12 hours; RNA was extracted 
and RT-PCR was performed for Edn1 and Edn2 expression to confirm gene loss. Grafted Edn2KO ovaries 
had significantly lower Edn1 (p = 0.006) and Edn2 (p < 0.001) expression than intact WT mice. Grafted WT 
ovaries trended towards decreased Edn2 expression (p = 0.086). (C) At hCG 24 hrs, ovaries were collected 
and serially sectioned. Images are shown grossly before removal from the kidney and at 4X. Grafted ovaries 
become flattened with a greater diameter and are less deep. Antral follicles, corpora lutea, and immature follicles 
were present in all groups. (D) Ovaries collected at hCG 24 hrs were serially sectioned. The total numbers of 
antral follicles (AF) and corpora lutea (CL) were determined (n = 5–7). Absolute counts are displayed at left 
and percentages are displayed at right. When compared to grafted WT ovaries, transplanted Edn2KO ovaries 
trended towards a higher percentage of antral follicles and fewer CL (p = 0.088). Grafted Edn2KO ovaries had 
significantly more oocytes trapped within corpora luteal (p = 0.010) and a significantly greater percentage of CL 
with trapped oocytes (p = 0.004). Errors bars represent the SEM. KOT = kidney-ovarian transplant.
www.nature.com/scientificreports/
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there were significantly more antral follicles (AF) but fewer CL in Edn2KO KOT ovaries than in WT intact ovaries 
(Fig. 2D, left). Similarly, there was significant difference in the percentage of AF and CL in Edn2KO KOT ovaries 
compared to WT (Fig. 2D, right). Importantly, Edn2KO KOT ovaries had a significantly increased percentage of 
oocytes trapped within CL compared to both WT intact and WT KOT ovaries (p = 0.004, 0.004, respectively). In 
Edn2KO ovaries, ovulation is impaired, but not completely abolished. Additionally, there was a greater percentage 
of AF and decreased percentage of CL in WT KOT ovaries compared to WT intact owing to surgical intervention. 
No differences in serum hormone concentrations of progesterone, 5β-corticosterone, or deoxycorticosterone 
(Figure S1) were observed at hCG12 or hCG24 hours. Taken together, these data demonstrate that ovulatory 
capacity is severely compromised in the Edn2KO ovary.
Selective deletion of Edn2 in the granulosa cells impairs ovulation. To overcome limitations of sur-
gical transplantation, conditional Edn2 knockout mice were generated. Three different mouse strains expressing 
Cre recombinase (or codon-improved Cre recombinase50, iCre) under the promoters of progesterone receptor 
(Pgr), aromatase (Cyp19), and estrogen receptor beta (ER-β; Esr2) were crossed with Edn2Flox mice. All mice 
expressed Cre in the granulosa cells. Expression of Pgr occurs in the granulosa cells of preovulatory follicles 
nine to six hours prior to ovulation in the mouse47, 51; Cyp19 expression begins in the secondary follicles to allow 
estrogen production52, 53; and Esr2 expression occurs within the granulosa cells of primary follicles following 
recruitment40, 43, 54. RT-PCR for Edn2 at hCG12 revealed a graded decrease in expression relative to the time of 
Cre expression. Cyp19-Edn2KO and Esr2-Edn2KO mice had significantly reduced Edn2 expression at hCG12 
hours, while Pgr-Edn2KO mice had partially reduced mean Edn2 expression that was not statistically signifi-
cant (Fig. 3A). No changes in Edn1 expression were observed. When examined histologically at hCG24, there 
was no difference in the number of hemorrhagic follicles, but Cyp19-Edn2KO and Esr2-Edn2KO ovaries had 
visibly more unruptured follicles present containing entrapped oocytes (Fig. 3B), similar to whole-ovary Edn2 
loss. Examination of the oviducts of ovulation-induced mice showed that Esr2-Edn2KO mice had significantly 
less oocytes than WT controls (3.75 ± 0.88 vs 16.36 ± 1.85 oocytes per ovary, p < 0.001), suggesting a defect in 
oocyte expulsion when Edn2 is lost in the granulosa cells. To further probe this, a fertility assay with WT males 
revealed no significant difference in the percentage of litters born per pairing in any genotype (Fig. 3C). The aver-
age number of pups per litter was significantly reduced in Cyp19-Edn2KO and Esr2-Edn2KO mice compared to 
WT mice (4.67 ± 0.71 and 4.29 ± 1.02 vs. 8.50 ± 0.60, p = 0.022 and 0.008, respectively), directly associated to the 
difference in oocytes ovulated and Edn2 expression. Pups were of normal weight at birth and matured normally. 
In particular, in the Esr2-Edn2KO mice gonadotropin stimulation resulted in ovulation of only four oocytes and 
the birth of four pups/litter on average, thus indicating that defects are likely exclusively in the ovulatory capacity 
in these mice. Pgr-Edn2KO mice displayed fertility and fecundity comparable to control mice and no significant 
ovulatory defect as well.
Figure 3. Loss of EDN2 reduces oocytes ovulated and decreases average litter size. Edn2flox mice were crossed 
with Pgr-Cre, Cyp19-iCre, and Esr2-iCre mice to remove Edn2 expression in granulosa cells. (A) Relative Edn2 
mRNA expression in whole ovaries compared to WT hCG12 ovaries. Expression of Edn2 is significantly lower 
in WT mice at hCG0 and in Cyp19-Edn2KO and Esr2-Edn2KO mice at hCG12 hours. (B) Representative 
histological images from ovaries of each genotype at hCG24 hours (4X). Ovaries from each genotype appeared 
healthy and all had corpora lutea, antral follicles, and immature follicles with no difference in hemorrhage 
between groups. Note the multiple antral follicles with trapped oocytes present in Cyp19-Edn2KO and Esr2-
Edn2KO mouse lines. (C) Breeding study and superovulation oocyte collection results. Each pairing lasted 10 
days; litter size represents pups present on day of birth; oocytes were collected from the ampulla of the oviduct 
at hCG24 hours. P-values are from the post hoc test relative to control mice. All error bars represent the SEM.
www.nature.com/scientificreports/
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Loss of EDN2 prevents transition from antral follicles to corpora lutea. Esr2-Edn2KO mice 
showed the greatest reduction in Edn2 expression among the conditional knockouts. Edn2 was reduced by 97.6% 
percent in Esr2-Edn2KO mice (Fig. 4A). Correspondingly, endothelin protein expression was significantly 
reduced in whole ovaries at hCG12 hours (Fig. 4B). Total endothelin protein was measured by EIA; antibodies 
used were unable to discriminate between EDN1, EDN2, EDN3, and their prepro-forms. As Edn1 and Edn3 
expression do not change in WT ovaries during ovulation47, the increase in endothelin peptide from hCG0 to 
hCG12 is presumed to be caused by an increase in Edn2 transcription. Lack of Edn2 upregulation thus accounts 
for the difference in endothelin protein content between WT and Esr2-Edn2KO mice at hCG12 hours. Multiple 
attempts at immunohistochemical localization of EDN2 using anti-EDN2 antibody (Abcam 197763)55 did not 
produce specific staining results (Figure S2). IHC staining was similar between WT, global Edn2KO, and granu-
losa cell-specific Edn2KO tissues and did not match phenotypic defects observed in global Edn2KO mice (expi-
ration at eight days of age). As anti-Edn2 antibody was not specific for EDN2, it was not used to evaluate Edn2 
expression or EDN2 localization. Instead qRT-PCR and Immunometric ELISA quantification methods, which 
were consistent with each other as well as phenotypic data, were employed. The change in endothelin peptide 
produced a minor impact on serum progesterone concentration following ovulation at hCG24 hours (Fig. 4C). 
The trend towards decreased progesterone may be attributed to the lack of CL formed in Esr2-Edn2KO mice and 
high variability in WT measurements.
To quantify the differences in CL, or other ovarian structures present, follicle counting was performed on 
Esr2-Edn2KO ovaries from hCG24 hours after serial sectioning. Esr2-Edn2KO had significantly more antral 
follicles by total count and percentage, and a trend towards a lower percentage of CL (Fig. 4D, p = 0.07). The dif-
ference in antral follicles present (about 10AF) accounts for the difference in CL present (about 5CL) when con-
sidering that not all AF may form CL after ovulation. Based on the increased number of antral follicles entrapped 
oocytes, the fewer corpora lutea, and the increased number of trapped oocytes, loss of EDN2 results in reduced 
ovulation from an obvious defect in follicular rupture with subsequent lack of CL formation. Of note, pregnancy 
proceeds normally following ovulation in the Esr2-Edn2KO and luteinization occurs.
Ednra ablation in granulosa cells has a minor impact on ovulation. In mammals, endothelins exert 
their actions through two receptors, EDNRA and EDNRB. EDNRA has been previously implicated in EDN2 
signaling and impaired ovulation via ovarian contraction5, 6, 11, 56. To first examine the hypothesis that ovulation 
is impaired without EDNRA signaling, Esr2-EdnraKO mice which lack Ednra in the granulosa cells were gener-
ated by crossing Esr2-iCre mice with floxed Ednra mice. Immature female mice were superovulated and oocytes 
Figure 4. Esr2-Edn2KO mice have more antral follicles and fewer corpora lutea after ovulation. (A) Taqman 
quantitative RT-PCR results comparing Edn2 expression in WT and Esr2-Edn2KO mice at hCG12 hours; 97.6% 
of Edn2 expression is lost. (B) ELISA quantitation of total Endothelin protein per ovary. Endothelin mass is 
significantly reduced at hCG12 hours in Esr2-Edn2KO mice and is not different at hCG0 hours from WT mice. 
(C) Serum was extracted from PND25 mice at hCG24 hours and serum hormone concentrations (ng/mL) were 
quantified by LC/MS/MS. P-values represent ANOVA score by hormone. Error bars represent the SEM. (D) 
Ovaries were collected at hCG24 hours from PND25 mice, fixed, and serially sectioned. The absolute number of 
corpora lutea (CL), antral follicles (AF), and follicles with hemorrhage present were counted. The value is also 
expressed as a percentage of total ovarian structures. Error bars represent the SEM.
www.nature.com/scientificreports/
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were collected at hCG24 hours. Esr2-EdnraKO mice showed reduced ovulatory ability (10.2 ± 1.9 vs 21.7 ± 2.0 
oocytes/ovary, p = 0.002) (Fig. 5A). Histologically, ovaries appeared similar to controls and possessed multiple 
corpora lutea as well as antral follicles (Fig. 5B). Esr2-EdnraKO mice also underwent a breeding study where 
one female and one WT female were paired together with the same male that had successfully sired previous 
litters (n = 4). There was no difference in fertility between WT and Esr2-EdnraKO mice, and there was also no 
significant difference in the number of pups per litter (5.0 ± 0.58 vs 4.7 ± 1.20, Fig. 5C). There was similarly no 
histological difference between ovaries following the fertility assay, and multiple CL were preset in each geno-
type (Fig. 5D). These data suggest that there is some EDNRA involvement in EDN2 signaling to granulosa cells, 
but the ovaries appear histologically different after superovulation from Esr2-Edn2KO ovaries. Although there 
was no difference in this fertility study from WT mice, the fecundity of Esr2-EdnraKO mice is similar to that of 
Esr2-Edn2KO mice (Fig. 3C). Therefore, Ednra expression in granulosa cells is involved in EDN2 signaling dur-
ing ovulation, but is likely not the only important source of signaling.
EDN2 induces contraction in mouse ovaries and uteri. To further explore the mechanism behind 
EDN2-mediated oocyte release, isometric contractions were performed on WT ovaries at hCG12–16 hours 
using a myograph tensile analysis. This is similar to previous studies performed on rat ovaries5 and confirms 
EDN2-induced contraction in mouse ovaries as well. First, the response of WT ovaries to different concentrations 
of EDN2 was demonstrated (Figure S3). Following mounting onto two pins, ovaries were normalized to 60 mM 
potassium in physiological saline solution (K + PSS) and then exposed to increasing concentrations of EDN2 in 
PSS, from 50 pM to 50 nM (n = 4). Contraction increased linearly in response to increasing doses of EDN2. At 
50 nM, contraction response reached a near maximum with little increase in tension from previous concentration 
(Figure S3). Importantly, the 50 nM concentration was subsequently used to treat ovaries and uteri of WT mice to 
determine the contractile response (Fig. 6). This concentration agreed with previously employed values by Ko et al.5  
in rats and allows for simple comparison. The average increase in tension from baseline in response to 50 nM 
EDN2 for a mouse ovary was 0.39 mN, or about 2.2 times the average response to K + PSS. Mouse uteri, which 
have significantly more smooth muscle and which also functioned as an internal control, demonstrated a greater 
tensile response to EDN2, 3.6 mN or about 2.6 times the average response to K + PSS. To confirm that this con-
traction was specific to endothelin receptors, the dual endothelin receptor antagonist tezosentan was added at a 
concentration of 140 nM after EDN2 and without washing away the EDN2 ligand solution. This concentration of 
tezosentan was previously shown to completely prevent EDN2-induced contraction when administered prior to 
EDN2 (data not shown). The average reduction in ovarian tension after tezosentan was 0.18 mN and −0.9 times 
the response to K + PSS; similarly, the response to tezosentan in uteri was 2.1 mN and −2.6 times the response to 
K + PSS (Fig. 6). Thus, EDN2 induces a consistent and strong contraction in both mouse ovaries and uteri that 
is greater in magnitude than treatment with a 60 mM potassium solution and which may be sufficient to induce 
oocyte expulsion during ovulation.
Figure 5. Ablation of Ednra in granulosa cells reduces ovulation. Ednra-flox mice were bred with Esr2-
iCre mice to produce Esr2-EdnraKO mice. (A) After superovulation, oocytes were collected and counted at 
hCG24 hrs. Esr2-EdnraKO mice ovulated significantly fewer oocytes than WT controls, and had a greater 
range of oocytes ovulated. Error bars represent the SEM; diamonds indicate each data point. (B) Histology of 
representative ovaries at hCG24 hrs from each genotype, 4X. (C) WT and Esr2-EdnraKO female mice were bred 
with control proven males, one male and one female of each genotype per cage for 10 days. The percentage of 
females that gave births and the number of pups per litter quantified. There was no difference between groups. 
(D) Histology of representative ovaries after breeding study, 4x. Multiple corpora lutea were present in each 
group.
www.nature.com/scientificreports/
7Scientific RepoRts | 7: 817  | DOI:10.1038/s41598-017-00943-w
Discussion
A surgical mouse model and multiple conditional knockout mouse models were used to demonstrate that Edn2 
is necessary for normal ovulation, and that this occurs through a contractile mechanism at the level of the ovary. 
Conditional deletion of Edn2 in the ovary results in decreased ovulation, and consequently fewer pups per litter, 
fewer corpora lutea, and increased antral follicles with entrapped oocytes present within the ovary. To our best 
knowledge, this is the first study utilizing conditional Edn2 loss within the murine ovary and the resulting effects 
on fertility and fecundity. These model animals are available for future utilization to investigate the underlying 
mechanisms of EDN2 and its induction as well.
In Edn2KO mice, systemic loss of Edn2 causes early juvenile death likely through starvation, though ovarian 
development is only slightly affected by PND6. There was a trend towards a lower percentage of primordial fol-
licles in Edn2KO ovaries, indicating that germ cell maturation into primordial follicles may be slighted retarded, 
yet generally proceeds similar to WT animals. Thus, the extraovarian effects of EDN2 are negligible for ovarian 
development in Edn2KO animals. Following surgical transplantation, ovarian function remained intact until 
the point of ovulation, though ovulation beneath the kidney capsule was not observed. Lack of blood flow to the 
ovary (ischemia) is the main complication following surgery that prevents ovarian survival57–60. Reformation 
of vessels takes more than 48 hours after ovarian grafting61, 62, but corpora lutea are present within 7 days in 
non-stimulated ovaries63. After transplantation, whole-ovarian loss of EDN2 does not prevent histologically iden-
tifiable CL formation in healthy adult mice, despite impaired follicle. The Edn2KO mice generated were similar 
to previous reports on global Edn2 loss by Chang et al.33, though Edn2KO mice used in this study were generated 
by ablating the second exon which encodes the entire biologically active peptide sequence, which may account 
for the slightly shorter lifespan reported herein. Edn2KO ovaries transplanted to the kidney (KOT) had decreased 
ovulatory ability and had more trapped oocytes present than transplanted WT ovaries. These ovaries also had 
fewer CL than intact WT ovaries. The number of CL may be considered a marker for the number of potential 
ovulation, though it must be noted that the recipient mice were old enough to enter a natural estrus and present 
CL may be resultant from ovulation prior to superovulation induction as mouse CL persist for multiple estrous 
cycles64. Decreased Edn2 expression in wtKOT mice was unexpected and may be a component of decreased vas-
culature present in the transplanted ovaries relative to intact age-matched mice. Of key note from this surgical 
experiment set is the increase in CL with trapped oocytes between WT KOT and Edn2KO KOT ovaries. Similar 
significant differences between these groups would likely have appeared with increased n-values, although this 
would require significant loss of life through surgery and non-viable Edn2KO mouse generation.
Granulosa cell-specific loss of Edn2 at various times during folliculogenesis caused smaller litter size (sub-
fecundity) and fewer oocytes ovulated (“subfertility”), although all mice retained the ability to give birth to 
healthy pups and to form morphologically normal corpora lutea. The range of severity varied with timing of Cre 
expression, which was likely because of the time required for Cre recombinase to remove Edn2. A new Esr2-iCre 
mouse successfully ablated the majority of ovarian Edn2 expression and protein production during ovulation. 
Specific anti-EDN2 antibodies were not available and potential differences in locality of EDN2 could not be 
defined; EDN2 is a diffusible and very short peptide (21 a.a), and is likely difficult to be specifically detected by 
IHC. The Esr2-Edn2KO mice had few changes in gene expression at hCG12 hours, though ovarian EDN2 pro-
tein content was sharply reduced. Instead, the cause of subfertility occurred through the normal contractile and 
Figure 6. EDN2 induces contraction in mouse ovaries and uteri in an Endothelin receptor-dependent manner. 
WT mice were superovulated and ovaries (n = 8) were collected at hCG12–16 hours and were placed in a 
myograph machine for tension analysis. (A) A representative control ovary response to a 60 mM K + PSS 
solution (for normalization), a 50 nM EDN2 solution, and a 140 nM tezosentan solution to block Endothelin 
receptors. This treatment schema was similarly used to measure responses in (B) WT uteri (n = 5). Vertical axis: 
tension in millinewtons where 9.81 mN = 1.00 gram-force. Horizontal axis: Time (Hours:Minutes:Seconds). 
(C) Comparison of absolute tension changes between tissues in response to Endothelin receptor agonization 
and subsequent antagonization. (D) Ovarian and uterine contraction normalized to the response to K + PSS to 
compare relative contractile responses. Error bars represent the SEM.
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vasoconstrictive properties of EDN2. Mice subsequently had more antral follicles and fewer corpora lutea. These 
data support that EDN2 acts as a tensile trigger for ovulation by causing contraction in either the theca externa 
layer or the associated vascular smooth muscle cells. The loss of the oocyte from the AF or blood vessel rupture 
are likely similarly important for induction of luteinization. Speculatively, EDN2 may also influence tension in 
the oviduct or uterus to increase the frequency or intensity of their continual contractions for fluid or germ cell 
transport. Future studies may focus on the physiological role of EDN2 by supplementing endothelins to condi-
tional knockout mice during ovulation compared to other contractile agents that act through unchanged receptor 
pathways. Importantly, this study also compares various granulosa-cell specific Cre mouse lines; when removing 
gene expression in mature ovaries, Esr2-iCre had superior efficacy to Pgr-Cre and Cyp19-iCre in reduction of 
Edn2 expression. Though Cyp19-iCre seems to trend towards a decrease in the number of oocytes ovulated, the 
significant decrease in pups per litter indicates either that loss of Edn2 at the time of aromatase expression is suffi-
cient to prevent normal follicle rupture, or that Cyp19-iCre expression has incomplete removal of Edn2 through-
out all granulosa cells; the latter is supported through immunohistochemical staining (unpublished). Another 
point of this conditional knockout experiment to consider is the extraovarian expression of Edn2, specifically in 
the oviduct and uterus. Though it would not impact ovulation, phenotypic decreased fecundity may be partially 
dependent on changes in EDN2 in these organs.
Generation of Esr2-EdnraKO mice supports minor involvement of EDNRA in EDN2-mediated follicle rup-
ture in granulosa cells. These mice ovulated fewer oocytes and gave birth to relatively small litters, though control 
mice also gave birth to fewer pups than would be expected for C57B/6 mice. Esr2-EdnraKO mice did not have as 
severe deficits as Esr2-Edn2KO mice. A less severe phenotype is also supported by ovarian histology, which indi-
cates that many CL were present and relative few antral follicles or antral follicles with trapped oocytes were pres-
ent. As Esr2-iCre removed Ednra in the granulosa cells40, EDN2 may have a minor function in granulosa cells that 
is not critical for ovulation. This granulosa cell effect may impact ovulation partially or indirectly, but it is more 
likely EDN2 signaling through smooth muscle receptors that has a severe and important impact on ovulation.
This study further presents data on mouse ovarian contraction relative to EDN2 treatment which replicates 
previous rat data. Work by Ko et al.5 demonstrate that rat ovaries contract in response to EDN2 at a 50 nM dose 
and that this tension can be modified by treatment with tezosentan at 605 nM (10 mg/mL) as well, when com-
pared to a K + control. The presented data show that EDN2 at 50 nM produces a similar relative response in 
mouse ovaries and that tezosentan reduces this contraction, though at approximately 15% the dose of tezosentan 
previously reported. The dose of EDN2 used for contraction in these experiments was equivalent to that used in 
previous rat studies.
In conclusion, the perspective that EDN2 is crucial for ovarian contraction and subsequent ovulation adds 
to a more comprehensive knowledge of the ovulatory process, and may contribute in the future to contraceptive 
or pro-fertility treatments. EDN2, or its receptors, may be inhibited in a potential novel non-hormonal contra-
ceptive, or ovarian vasoconstriction may be stimulated to help women undergoing artificially induced ovulation 
treatment.
Methods
See SI Materials and Methods for detailed methods. This study was carried out in accordance with the recommen-
dations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. Animal pro-
tocol was approved by the University of Illinois Animal Care and Use Committee (Protocols: 11184, 12090, 13032, 
14222, and 14247), and all efforts were made to minimize animal suffering. Results are expressed as mean ± SEM.
Animals used. Mice were generated by crossing Edn2flox/flox mice purchased from Jackson Laboratory65 
with Pgr-Cre mice34, Cyp19-iCre mice35, and knock-in Esr2-iCre mice40, or with Zp3-Cre mice32 to generate 
global Edn2 knockout mice (Edn2KO). Ednraflox/flox mice were bred with Esr2-iCre mice66 to remove Ednra in 
the granulosa cells.
Kidney-Ovarian Transplantation (KOT). Ovaries were grafted under the kidney capsule following meth-
ods developed by Jackson Laboratories. The recipient female mice, at the age of 30 days, were anesthetized by 
isoflurane and an incision was made between the last rib and the iliac crest. Ovaries were removed after clamp-
ing the ovarian blood vessels (ovariectomy). The kidney was exposed through the same incision site and the 
post-natal day six (PND6) donor ovary was pushed through the incision and pushed to the opposite pole of the 
kidney. The incision was sutured closed and repeated on the opposite side. Mice were allowed to recover for 19 
days post-surgery.
Fertility assay, Superovulation, RT-PCR, and Histology. For fertility assay, each set of females was 
paired for 10 days with a proven WT male breeder, then separated and monitored daily. Litter size describes the 
number of pups present at birth; age refers to the start of mating period. Superovulation was performed by sin-
gle injection of 5IU PMSG and 5IU hCG at 48 hour intervals to 25 day old mice (ovarian age 25 days in ovarian 
transplant mice). Mice were sacrificed 12 or 24 hrs after hCG injection. At 12 hrs after, RNA was extracted and 
purified. Complementary DNA was generated and qRT-PCR was done for Edn1 and Edn2, with Rpl19 as an 
internal control. Data were analyzed using the delta delta Ct67 method. For histology, ovaries from hCG24 hours 
were fixed, embedded in paraffin, sectioned at 5 μm, and stained with hematoxylin and eosin for follicle counting. 
AF were histologically defined as spaces containing an oocyte with continuous fluid 100 um in diameter; CL were 
defined as cellular and/or partially eosinophilic fluid-filled spaces lined by polygonal eosinophilic cells containing 
lipid droplets.
Endothelin Protein Quantification. Soluble endothelins were extracted from hCG12 hrs ovaries with 1 M 
HCl in 100% ethanol. After ethanol evaporation, a commercial ELISA kit (583151 Cayman Chemical) was run 
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according to the manufacturer’s instructions. Plates were read at 405 nm and analyzed with a quadratic standard 
curve.
Serum Steroid Measurement. Samples were prepared by removing the serum supernatant. Ten μL of 
mouse serum was mixed with 50 μL methanol and 1 μL of 2 μg/mL D9-progesterone. The supernatant was sub-
jected to LC/MS/MS injection at the Metabolomics Center at the University of Illinois at Urbana-Champaign. 
Double charcoal-stripped steroid free mouse serum was used as a standard. For detection, samples were analyzed 
with the 5500 QTRAP LC/MS/MS system (AB Sciex, Foster City, CA) in Metabolomics Lab of Roy J. Carver 
Biotechnology Center.
Ovary Mounting and Isometric Tension Measurement. Whole ovaries used for tension analysis were 
placed into a physiological saline solution (PSS) at 37 °C in a wire myograph system (Tissue Bath System 620 M, 
Danish Myo Technology, DMT-USA Inc., Ann Arbor, MI). Each ovary was mounted with 4 mm pins on each 
myograph arm. Ovarian tensile measurements were recorded via LabChart software with a constant tension 
of 1 mN. A ‘wake-up’ protocol was used for equilibration: K + PSS was applied to the stretched ovary, and was 
removed 3 min later. The ovary was then washed 4 times over 5 min with PSS, and allowed to sit for 5 more min. 
This procedure was repeated twice. The contractile experiment began at time zero. K + PSS solution was applied 
a 3rd time for a duration of 5 min to serve as a reference point. K + PSS was then removed with four PSS washes. 
Next, human endothelin-2 purified peptide (American Peptide Co, Sunnyvale, CA) was added to the PSS solution 
at a 50 nM concentration. After 20 min. the dual-endothelin receptor antagonist drug tezosentan (tezo) was added 
to a concentration of 140 nM. Fifty nM of EDN2 was the lowest dose that consistently produced the strongest 
contraction (Figure S3). Similar methods were used for uterine tissue mounted longitudinally between two pins.
Statistical Analysis. Data analyses were performed using statistical software (SPSS 22.0, Chicago, IL). 
Continuous data were tested for normal distribution by a Shapiro-Wilk test. Following homogeneity of variance 
confirmation, all normally distributed continuous data were analyzed with parametric tests and a Bonferroni post 
hoc test. All non-normally distributed continuous data were transformed by log function to a normal distribution 
if possible or analyzed by non-parametric tests (Mann Whitney U, Kruskal Wallis ANOVA). Ordinal data were 
similarly analyzed. Data are graphically presented as the mean and standard error of the mean unless otherwise 
indicated. For all analyses the alpha value was set to 0.05.
References
 1. Yanagisawa, M. et al. Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor 
peptide. Proc Natl Acad Sci USA 85, 6964–6967, doi:10.1073/pnas.85.18.6964 (1988).
 2. Horinouchi, T., Terada, K., Higashi, T. & Miwa, S. Endothelin receptor signaling: new insight into its regulatory mechanisms. J 
Pharmacol Sci 123, 85–101, doi:10.1254/jphs.13R02CR (2013).
 3. Ko, C., Meidan, R. & Bridges, P. J. Why two endothelins and two receptors for ovulation and luteal regulation? Life Sci 91, 501–506, 
doi:10.1016/j.lfs.2012.05.010 (2012).
 4. Cacioppo, J., Koo, Y., Lin, P. C., Gal, A. & Ko, C. Generation and characterization of an Endothelin-2 iCre mouse. Genesis 53, 245–56, 
doi:10.1002/dvg.22845 (2015).
 5. Ko, C. et al. Endothelin-2 in ovarian follicle rupture. Endocrinology 147, 1770–1779, doi:10.1210/en.2005-1228 (2006).
 6. Palanisamy, G. S. et al. A novel pathway involving progesterone receptor, endothelin-2, and endothelin receptor B controls ovulation 
in mice. Mol Endocrinol 20, 2784–2795, doi:10.1210/me.2006-0093 (2006).
 7. Choi, D. H. et al. Expression pattern of endothelin system components and localization of smooth muscle cells in the human pre-
ovulatory follicle. Hum Reprod 26, 1171–1180, doi:10.1093/humrep/der066 (2011).
 8. Richards, J. S. Genetics of ovulation. Semin Reprod Med 25, 235–242, doi:10.1055/s-2007-980217 (2007).
 9. Ujioka, T., Russell, D. L., Okamura, H., Richards, J. S. & Espey, L. L. Expression of regulator of G-protein signaling protein-2 gene in 
the rat ovary at the time of ovulation. Biol Reprod 63, 1513–1517, doi:10.1095/biolreprod63.5.1513 (2000).
 10. Cacioppo, J. A. et al. Loss of function of endothelin-2 leads to reduced ovulation and CL formation. PLoS One 9, e96115, doi:10.1371/
journal.pone.0096115 (2014).
 11. Bridges, P. J. et al. Production and binding of endothelin-2 (EDN2) in the rat ovary: endothelin receptor subtype A (EDNRA)-
mediated contraction. Reprod Fertil Dev 22, 780–787, doi:10.1071/RD09194 (2010).
 12. Hosoda, K. et al. Cloning and expression of human endothelin-1 receptor cDNA. FEBS Lett 287, 23–26, doi:10.1016/0014-
5793(91)80007-P (1991).
 13. Ogawa, Y. et al. Molecular cloning of a non-isopeptide-selective human endothelin receptor. Biochem Biophys Res Commun 178, 
248–255, doi:10.1016/0006-291X(91)91806-N (1991).
 14. Warner, T. D., Mitchell, J. A., de Nucci, G. & Vane, J. R. Endothelin-1 and endothelin-3 release EDRF from isolated perfused arterial 
vessels of the rat and rabbit. J Cardiovasc Pharmacol 13(Suppl 5), S85–88, doi:10.1097/00005344-198900135-00021 (1989). 
discussion S102.
 15. de Nucci, G. et al. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release 
of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 85, 9797–9800, doi:10.1073/pnas.85.24.9797 
(1988).
 16. Fukuroda, T. et al. Clearance of circulating endothelin-1 by ETB receptors in rats. Biochem Biophys Res Commun 199, 1461–1465, 
doi:10.1006/bbrc.1994.1395 (1994).
 17. Dupuis, J., Goresky, C. A. & Fournier, A. Pulmonary clearance of circulating endothelin-1 in dogs in vivo: exclusive role of ETB 
receptors. J Appl Physiol (1985) 81, 1510–1515, doi:10.1016/S0735-1097(96)80628-0 (1996).
 18. Migone, F. F. et al. In vivo imaging reveals an essential role of vasoconstriction in rupture of the ovarian follicle at ovulation. Proc Natl 
Acad Sci USA 113, 2294–2299, doi:10.1073/pnas.1512304113 (2016).
 19. Wulff, C., Dickson, S. E., Duncan, W. C. & Fraser, H. M. Angiogenesis in the human corpus luteum: simulated early pregnancy by 
HCG treatment is associated with both angiogenesis and vessel stabilization. Hum Reprod 16, 2515–2524 (2001).
 20. Burden, H. W. Adrenergic innervation in ovaries of the rat and guinea pig. Am J Anat 133, 455–461, doi:10.1002/aja.1001330407 
(1972).
 21. Burden, H. W. Ultrastructural observations on ovarian perifollicular smooth muscle in the cat, guinea pig, and rabbit. Am J Anat 
133, 125–142, doi:10.1002/aja.1001330202 (1972).
 22. Espey, L. L. Ovarian contractility and its relationship to ovulation: a review. Biol Reprod 19, 540–551, doi:10.1095/biolreprod19.3.540 
(1978).
www.nature.com/scientificreports/
1 0Scientific RepoRts | 7: 817  | DOI:10.1038/s41598-017-00943-w
 23. Palti, Z. & Freund, M. Spontaneous contractions of the human ovary in vitro. J Reprod Fertil 28, 113–115, doi:10.1530/jrf.0.0280113 
(1972).
 24. Gimeno, M. F., Borda, E., Sterin-Borda, L., Vidal, J. H. & Gimeno, A. L. Pharmacologic influences on human ovarian contractions. 
Obstet Gynecol 47, 218–222 (1976).
 25. Sterin-Borda, L., Borda, E., Gimeno, M. F. & Gimeno, A. L. Spontaneous and prostaglandin- or oxytocin-induced motility of rat 
ovaries isolated during different stages of the estrous cycle: effects of norepinephrine. Fertil Steril 27, 319–327 (1976).
 26. Rocereto, T., Jacobowitz, D. & Wallach, E. E. Observations of spontaneous contractions of the cat ovary in vitro. Endocrinology 84, 
1336–1341, doi:10.1210/endo-84-6-1336 (1969).
 27. Virutamasen, P., Smitasiri, Y. & Fuchs, A. R. Intraovarian pressure changes during ovulation in rabbits. Fertil Steril 27, 188–196 
(1976).
 28. Virutamasen, P., Wright, K. H. & Wallach, E. E. Effects of prostaglandins E 2 and F 2 on ovarian contractility in the rabbit. Fertil Steril 
23, 675–682 (1972).
 29. Virutamasen, P., Wright, K. H. & Wallach, E. E. Effects of catecholamines on ovarian contractility in the rabbit. Obstet Gynecol 39, 
225–236 (1972).
 30. Cho, J., Kim, H., Kang, D. W., Yanagisawa, M. & Ko, C. Endothelin B receptor is not required but necessary for finite regulation of 
ovulation. Life Sci 91, 613–617, doi:10.1016/j.lfs.2012.02.016 (2012).
 31. Rossant, J. & McMahon, A. “Cre”-ating mouse mutants-a meeting review on conditional mouse genetics. Genes Dev 13, 142–145, 
doi:10.1101/gad.13.2.142 (1999).
 32. de Vries, W. N. et al. Expression of Cre recombinase in mouse oocytes: a means to study maternal effect genes. Genesis 26, 110–112, 
doi:10.1002/(SICI)1526-968X(200002)26:2&lt;&gt;1.0.CO;2-T (2000).
 33. Chang, I. et al. Endothelin-2 deficiency causes growth retardation, hypothermia, and emphysema in mice. J Clin Invest 123, 
2643–2653, doi:10.1172/JCI66735 (2013).
 34. Soyal, S. M. et al. Cre-mediated recombination in cell lineages that express the progesterone receptor. Genesis 41, 58–66, doi:10.1002/
gene.20098 (2005).
 35. Fan, H. Y. et al. Selective expression of KrasG12D in granulosa cells of the mouse ovary causes defects in follicle development and 
ovulation. Development 135, 2127–2137, doi:10.1242/dev.020560 (2008).
 36. Mueller, S. O., Katzenellenbogen, J. A. & Korach, K. S. Endogenous estrogen receptor beta is transcriptionally active in primary 
ovarian cells from estrogen receptor knockout mice. Steroids 69, 681–686, doi:10.1016/j.steroids.2004.06.004 (2004).
 37. Jakimiuk, A. J., Weitsman, S. R., Yen, H. W., Bogusiewicz, M. & Magoffin, D. A. Estrogen receptor alpha and beta expression in theca 
and granulosa cells from women with polycystic ovary syndrome. J Clin Endocrinol Metab 87, 5532–5538, doi:10.1210/jc.2002-
020323 (2002).
 38. Choi, I. et al. Human estrogen receptor beta-specific monoclonal antibodies: characterization and use in studies of estrogen receptor 
beta protein expression in reproductive tissues. Mol Cell Endocrinol 181, 139–150, doi:10.1016/S0303-7207(01)00492-0 (2001).
 39. Slomczynska, M. & Wozniak, J. Differential distribution of estrogen receptor-beta and estrogen receptor-alpha in the porcine ovary. 
Exp Clin Endocrinol Diabetes 109, 238–244, doi:10.1055/s-2001-15112 (2001).
 40. Cacioppo, J. A. et al. Generation of an estrogen receptor beta-iCre knock-in mouse. Genesis 54, 38–52, doi:10.1002/dvg.22911 
(2016).
 41. Richards, J. S. et al. Novel signaling pathways that control ovarian follicular development, ovulation, and luteinization. Recent Prog 
Horm Res 57, 195–220, doi:10.1210/rp.57.1.195 (2002).
 42. Jansen, H. T., West, C., Lehman, M. N. & Padmanabhan, V. Ovarian estrogen receptor-beta (ERbeta) regulation: I. Changes in 
ERbeta messenger RNA expression prior to ovulation in the ewe. Biol Reprod 65, 866–872, doi:10.1095/biolreprod65.3.866 (2001).
 43. O’Brien, M. L., Park, K., In, Y. & Park-Sarge, O. K. Characterization of estrogen receptor-beta (ERbeta) messenger ribonucleic acid 
and protein expression in rat granulosa cells. Endocrinology 140, 4530–4541, doi:10.1210/endo.140.10.7032 (1999).
 44. Hickey, G. J., Krasnow, J. S., Beattie, W. G. & Richards, J. S. Aromatase cytochrome P450 in rat ovarian granulosa cells before and 
after luteinization: adenosine 3′,5′-monophosphate-dependent and independent regulation. Cloning and sequencing of rat 
aromatase cDNA and 5′ genomic DNA. Mol Endocrinol 4, 3–12, doi:10.1210/mend-4-1-3 (1990).
 45. Krasnow, J. S., Hickey, G. J. & Richards, J. S. Regulation of aromatase mRNA and estradiol biosynthesis in rat ovarian granulosa and 
luteal cells by prolactin. Mol Endocrinol 4, 13–12, doi:10.1210/mend-4-1-13 (1990).
 46. Richards, J. S. & Hedin, L. Molecular aspects of hormone action in ovarian follicular development, ovulation, and luteinization. 
Annu Rev Physiol 50, 441–463, doi:10.1146/annurev.ph.50.030188.002301 (1988).
 47. Jo, M. et al. Development and application of a rat ovarian gene expression database. Endocrinology 145, 5384–5396, doi:10.1210/
en.2004-0407 (2004).
 48. Robker, R. L. et al. Progesterone-regulated genes in the ovulation process: ADAMTS-1 and cathepsin L proteases. Proc Natl Acad Sci 
USA 97, 4689–4694, doi:10.1073/pnas.080073497 (2000).
 49. Bacon, C. R. & Davenport, A. P. Endothelin receptors in human coronary artery and aorta. Br J Pharmacol 117, 986–992, 
doi:10.1111/bph.1996.117.issue-5 (1996).
 50. Shimshek, D. R. et al. Codon-improved Cre recombinase (iCre) expression in the mouse. Genesis 32, 19–26, doi:10.1002/gene.v32:1 
(2002).
 51. Park, O. K. & Mayo, K. E. Transient expression of progesterone receptor messenger RNA in ovarian granulosa cells after the 
preovulatory luteinizing hormone surge. Mol Endocrinol 5, 967–978, doi:10.1210/mend-5-7-967 (1991).
 52. Burns, K. H., Yan, C., Kumar, T. R. & Matzuk, M. M. Analysis of ovarian gene expression in follicle-stimulating hormone beta 
knockout mice. Endocrinology 142, 2742–2751, doi:10.1210/endo.142.7.8279 (2001).
 53. Webb, R. et al. Molecular mechanisms regulating follicular recruitment and selection. J Reprod Fertil Suppl 54, 33–48 (1999).
 54. Chiang, C. H., Cheng, K. W., Igarashi, S., Nathwani, P. S. & Leung, P. C. Hormonal regulation of estrogen receptor alpha and beta 
gene expression in human granulosa-luteal cells in vitro. J Clin Endocrinol Metab 85, 3828–3839, doi:10.1210/jcem.85.10.6886 
(2000).
 55. Binz, N. et al. Effect of vascular endothelial growth factor upregulation on retinal gene expression in the Kimba mouse. Clin Exp 
Ophthalmol 41, 251–262, doi:10.1111/j.1442-9071.2012.02845.x (2013).
 56. Al-Alem, L. et al. Endothelin-2 induces oviductal contraction via endothelin receptor subtype A in rats. J Endocrinol 193, 383–391, 
doi:10.1677/JOE-07-0089 (2007).
 57. Aubard, Y. Ovarian tissue xenografting. Eur J Obstet Gynecol Reprod Biol 108, 14–18, doi:10.1016/S0301-2115(02)00424-4 (2003).
 58. Kim, S. S., Battaglia, D. E. & Soules, M. R. The future of human ovarian cryopreservation and transplantation: fertility and beyond. 
Fertil Steril 75, 1049–1056, doi:10.1016/S0015-0282(01)01790-3 (2001).
 59. Nisolle, M., Casanas-Roux, F., Qu, J., Motta, P. & Donnez, J. Histologic and ultrastructural evaluation of fresh and frozen-thawed 
human ovarian xenografts in nude mice. Fertil Steril 74, 122–129, doi:10.1016/S0015-0282(00)00548-3 (2000).
 60. Oktay, K., Newton, H., Aubard, Y., Salha, O. & Gosden, R. G. Cryopreservation of immature human oocytes and ovarian tissue: an 
emerging technology? Fertil Steril 69, 1–7, doi:10.1016/S0015-0282(97)00207-0 (1998).
 61. Dissen, G. A., Lara, H. E., Fahrenbach, W. H., Costa, M. E. & Ojeda, S. R. Immature rat ovaries become revascularized rapidly after 
autotransplantation and show a gonadotropin-dependent increase in angiogenic factor gene expression. Endocrinology 134, 
1146–1154, doi:10.1210/endo.134.3.8119153 (1994).
www.nature.com/scientificreports/
1 1Scientific RepoRts | 7: 817  | DOI:10.1038/s41598-017-00943-w
 62. Rone, J. D., Halvorson, L. M. & Goodman, A. L. Ovarian angiogenesis in rabbits: endotheliotrophic chemoattractant activity from 
isolated follicles and dispersed granulosa cells. J Reprod Fertil 97, 359–365, doi:10.1530/jrf.0.0970359 (1993).
 63. Yang, H., Lee, H. H., Lee, H. C., Ko, D. S. & Kim, S. S. Assessment of vascular endothelial growth factor expression and apoptosis in 
the ovarian graft: can exogenous gonadotropin promote angiogenesis after ovarian transplantation? Fertil Steril 90, 1550–1558, 
doi:10.1016/j.fertnstert.2007.08.086 (2008).
 64. Chaffin, C. L. & Vandevoort, C. A. Follicle growth, ovulation, and luteal formation in primates and rodents: a comparative 
perspective. Exp Biol Med (Maywood) 238, 539–548, doi:10.1177/1535370213489437 (2013).
 65. Rattner, A., Yu, H., Williams, J., Smallwood, P. M. & Nathans, J. Endothelin-2 signaling in the neural retina promotes the endothelial 
tip cell state and inhibits angiogenesis. Proc Natl Acad Sci USA 110, E3830–3839, doi:10.1073/pnas.1315509110 (2013).
 66. Kedzierski, R. M. et al. Cardiomyocyte-specific endothelin A receptor knockout mice have normal cardiac function and an unaltered 
hypertrophic response to angiotensin II and isoproterenol. Mol Cell Biol 23, 8226–8232, doi:10.1128/MCB.23.22.8226-8232.2003 
(2003).
 67. Schmittgen, T. D. & Livak, K. J. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3, 1101–1108, 
doi:10.1038/nprot.2008.73 (2008).
Acknowledgements
The authors thank Dr. Lucas Li for serum hormone measurements, Karen Doty and Dr. Juan Davila for 
histological assistance, Dr. Masashi Yanagisawa for Ednra-flox mice, Dr. Levent Dirikolu for pharmacological 
advice, Dr. James Park for assistance with the myograph machine, and Dr. Kee Jun Kim for hormone-stripped 
serum. This work was supported by NIH HD052694 and HD071875 to C.J.K.
Author Contributions
J.A.C. and C.J.K. were involved in research design; J.A.C., P.P.L., P.R.H., D.R.M., A.G., and C.J.K. were involved in 
data acquisition; J.A.C. and P.R.H. were involved in data analysis; J.A.C., P.P.L., P.R.H., D.R.M., A.G., and C.J.K. 
were involved in article drafting and revision.
Additional Information
Supplementary information accompanies this paper at doi:10.1038/s41598-017-00943-w
Competing Interests: The authors declare that they have no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2017
